Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Said A Al-Busafi

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of Clinical Medicine|December 17, 2024
Real-World Experience, Effectiveness, and Safety of Direct-Acting Antivirals for the Treatment of Hepatitis C in Oman: A Cross-Sectional, Multicenter StudyKhalid M Al-Naamani, Heba Omar, Said A Al Busafi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 8, 2025
Two-Decade Trends in MASLD and Its Complications in the Middle East and North Africa (2010-2021)Zobair M Younossi, James M Paik, Yusuf Yilmaz, et al.
The Lancet. Gastroenterology & Hepatology|November 12, 2020
Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north AfricaGamal Shiha, Khalid Alswat, Maryam Al Khatry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2025
Global Burden of Major Chronic Liver Diseases in 2021Gong Feng, Yusuf Yilmaz, Luca Valenti, et al.
The American Journal of Gastroenterology|January 3, 2025
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021Chutian Wu, Giovanni Targher, Christopher D Byrne, et al.
Annals of Hepatology|January 11, 2026
The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver diseaseYasser Fouad, Reda Elwakil, Faisal M Sanai, et al.
Eclinicalmedicine|December 6, 2024
Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021Xiao-Dong Zhou, Qin-Fen Chen, Wah Yang, et al.
Eclinicalmedicine|October 10, 2024
Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021Xiao-Dong Zhou, Qin-Fen Chen, Wah Yang, et al.
Metabolism: Clinical and Experimental|August 16, 2024
Global burden of metabolic diseases, 1990-2021Huai Zhang, Xiao-Dong Zhou, Michael D Shapiro, et al.
JHEP Reports : Innovation in Hepatology|July 8, 2026
Delphi survey to explore core curriculum for training the next-generation of hepatologists<sup>☆</sup>Xinyi Xu, Yu Shi, Frank Tacke, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Clinical Medicine|December 17, 2024
Real-World Experience, Effectiveness, and Safety of Direct-Acting Antivirals for the Treatment of Hepatitis C in Oman: A Cross-Sectional, Multicenter StudyKhalid M Al-Naamani, Heba Omar, Said A Al Busafi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 8, 2025
Two-Decade Trends in MASLD and Its Complications in the Middle East and North Africa (2010-2021)Zobair M Younossi, James M Paik, Yusuf Yilmaz, et al.
The Lancet. Gastroenterology & Hepatology|November 12, 2020
Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north AfricaGamal Shiha, Khalid Alswat, Maryam Al Khatry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2025
Global Burden of Major Chronic Liver Diseases in 2021Gong Feng, Yusuf Yilmaz, Luca Valenti, et al.
The American Journal of Gastroenterology|January 3, 2025
Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990-2021Chutian Wu, Giovanni Targher, Christopher D Byrne, et al.
Annals of Hepatology|January 11, 2026
The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver diseaseYasser Fouad, Reda Elwakil, Faisal M Sanai, et al.
Eclinicalmedicine|December 6, 2024
Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021Xiao-Dong Zhou, Qin-Fen Chen, Wah Yang, et al.
Eclinicalmedicine|October 10, 2024
Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021Xiao-Dong Zhou, Qin-Fen Chen, Wah Yang, et al.
Metabolism: Clinical and Experimental|August 16, 2024
Global burden of metabolic diseases, 1990-2021Huai Zhang, Xiao-Dong Zhou, Michael D Shapiro, et al.
JHEP Reports : Innovation in Hepatology|July 8, 2026
Delphi survey to explore core curriculum for training the next-generation of hepatologists<sup>☆</sup>Xinyi Xu, Yu Shi, Frank Tacke, et al.
Pageof 7